Related Experiment Videos
Neurologic drug-psychotropic drug update
James J Strain1, Anwarul Karim, Gina Caliendo
1Division of Behavioral Medicine and Consultation Psychiatry, Mount Sinai School of Medicine, Mount Sinai-NYU Medical Center/Health System, New York, NY 10029, USA. jim_strain@hotmail.com
General Hospital Psychiatry
|September 11, 2002
Summary
Neurologists and psychiatrists must understand drug interactions between neurology and psychotropic medications. Over 80 significant interactions were identified, highlighting potential risks in combined prescriptions.
Area of Science:
- Neuropharmacology
- Clinical Pharmacy
Background:
- Neurologists frequently prescribe psychotropic medications.
- Psychiatric consultants often recommend psychotropic drugs for patients with neurological conditions.
Purpose of the Study:
- To identify and analyze drug-drug interactions between neurology and psychotropic medications.
- To raise awareness among neurologists and psychiatrists regarding potential drug interactions.
Main Methods:
- Utilized six distinct methods for examining drug-drug interactions: PubMed (MEDLINE), Hanston's Drug Interaction Analysis and Management Text, Drug Interactions Facts, Micromedex Drug-dex, American Hospital Formulary Service Drug Information, and FDA MedWatch communications.
- Reviewed over eighty significant drug interactions (Level 1 - major, Level 2 - minor).
Main Results:
- Identified over eighty significant drug interactions between neurology and psychotropic drugs.
- Found that over one-third of commonly prescribed neurology medications are also used in psychiatry, sometimes for different indications (e.g., carbamazepine for seizures or mood stabilization).
Conclusions:
- Emphasizes the critical need for awareness of neurology-psychotropic drug interactions among both neurologists and psychiatrists.
- Highlights the overlap in medication prescribing between neurology and psychiatry, necessitating careful consideration of combined use to ensure patient safety.